@inproceedings{inproceedings, title  = {{Nab-paclitaxel or docetaxel; As alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): A cost utility analysis in five European countries}},

 url = {{}},

 year = {{2008}},

 month = {{5}},

 author = {{Dranitsaris G and Lidgren M and Lundkvist J and Coleman R}},

 volume = {{11}},

 journal = {{VALUE HEALTH}},

 issue = {{3}},

 pages = {{A71-A71}},

 note = {{Accessed on 2025/10/10}}}